Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
VHAQ.WS was delisted on the 23rd of October, 2023.
32 hedge funds and large institutions have $9.36M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
50% more capital invested
Capital invested by funds: $6.24M → $9.36M (+$3.13M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% more funds holding
Funds holding: 32 → 32 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$25.7K |
| 2 |
HHGC
Hunting Hill Global Capital
New York
|
+$1.41K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.16K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$273 |
| 5 |
VF
Virtu Financial
New York
|
+$58 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$6K |
| 3 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$2.84K |
| 4 |
CAC
Cowen and Company
New York
|
-$776 |
VHAQ.WS Hedge Fund Activity: Q2 2022 in Review
32 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q2 2022, worth a combined $9.36M — up 50% from $6.24M a quarter earlier.
Fund positioning in VHAQ.WS was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 3 trimmed.
The largest buyer was Radcliffe Capital Management, adding an estimated $25.7K. The largest seller was Citadel Advisors, cutting an estimated $38K.
- 32 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $9.36M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q2 2022, up 50% quarter-over-quarter.
- 2 funds opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q2 2022 and 2 closed out, a net change of 0 holders.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q2 2022 was Radcliffe Capital Management, an estimated $25.7K added.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q2 2022 was Citadel Advisors, an estimated $38K sold.
Based on aggregated 13F filings for Q2 2022.